Fabio Vasconcellos Comim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fabio Vasconcellos Comim has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
- Melissa Orlandin Premaor
Affiliation Department of Clinical Medicine, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil
22 shared publications - Rafael Noal Moresco
Graduate Program in Pharmaceutical Sciences, Center of Health Sciences, Federal University of Santa Maria, Santa Maria 97105-900, Brazil
14 shared publications - Paulo Bayard Dias Gonçalves
Universidade Federal de Santa Maria, Brasil
11 shared publications Etiane Tatsch
Laboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis Federal University of Santa Maria Santa Maria RS Brazil
7 shared publications- José Antonio Mainardi de Carvalho
Universidade Federal de Santa Maria
7 shared publications - Werner Giehl Glanzner
Department of Animal Science, McGill University, Macdonald Campus, Sainte Anne de Bellevue, QC H9X3V9, Canada
7 shared publications
Latest Publications
- 21 June 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (4) , e1205-e1206
Propionate Enhances the Browning of Adipose Mesenteric Tissue, Reduces Inflammation, and Increases Thermogenic Activity
- 21 June 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (4) , e1205-e1206
Propionate Enhances the Browning of Adipose Mesenteric Tissue, Reduces Inflammation, and Increases Thermogenic Activity
- 22 January 2025
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 133 (02) , 105-107
Anxiety and Depression in Polycystic Ovary Syndrome: An Analysis Using the Hospital Anxiety and Depression Scale (HADS) in Women from a Low-Income Country
Polycystic ovary syndrome (PCOS) is a complex disease and the most common endocrine condition that affects women of reproductive age. Its prevalence ranges from 5% to 20%, characterized by hyperandrogenism, menstrual irregularities, and the presence of polycystic and dysfunctional ovaries [1] [2] [3] [4] [5] [6]. Women with PCOS often suffer from a variety of psychiatric disorders [7]. PCOS is associated with a greater likelihood of developing anxiety and depression, with moderate/severe symptoms, compromising the success of clinical treatment [8] [9]. The relationship between these psychiatric disorders and PCOS is not clear, but it is bidirectional and complex, resulting from interactions between sociocultural, family, individual factors, and the syndrome itself [7] [10]. The Hospital Anxiety and Depression Scale (HADS) is a screening instrument validated in Portuguese and widely used in clinical context, as it is a simple, objective and effective method for identifying and monitoring the presence and severity of possible or probable cases of anxiety and depression [9]. It contains 14 items divided into subscale A (anxiety) and subscale D (depression) that are scored separately or by the sum of A and D. The higher the score, the greater the level of anxiety and/or depression. For each item, a 4-point response scale is used, ranging from 0 – “absence of symptoms” to 3 – “maximum symptoms”. A score of 0 to 7 indicates no anxiety and/or depression, a score of 8 to 10 indicates mild anxiety and/or depression, a score of 11 to 14 indicates moderate anxiety and/or depression, and a score of 15 to 21 indicates anxiety and/or severe depression. For each subscale (A and D), 0 to 21 points can be obtained [8] [9] [10]. The average per capita income of Brazilians is US$318, and Brazil ranks 89th in the Human Development Index, according to the United Nations Organization [11] [12]. Low-income countries, such as Brazil, present a higher risk of psychiatric diseases due to less favorable socioeconomic conditions, making it not possible to extrapolate epidemiological data from PCOS patients who live in developed countries. Therefore, the objective of this study was to compare the HADS between Brazilian women with PCOS and a healthy control group, and its relationship with anthropometric variables. This case-control study was approved by the Research Ethics Committee of the Federal University of Minas Gerais (n. CAAE 05398918.2.0000.5149). Data were collected after consent and signing of the Informed Consent Form. This study was carried out from February to December 2023, with 47 women with PCOS, in which the diagnosis was established according to the criteria by the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine PCOS Consensus Workshop Group (Rotterdam) [13]. The control group included 47 healthy women, who presented regular ovulatory cycles, normal androgen levels, and no hirsutism. Women over 40 years of age, pregnant or undergoing nutritional monitoring were excluded. The groups were assessed by a trained nutritionist, who applied the HADS to both groups, measuring weight and height on a calibrated scale in both groups for body mass index (BMI) determination. Arm (AC), waist (WC), and hip circumferences (HC) were measured with an inelastic tape only in the PCOS group. Statistical analyses were performed using SPSS version 21.0 software. Normality was assessed using the Shapiro-Wilk test. Data were expressed as median and interquartile range (IQ: third quartile – first quartile). The Spearman test was performed to evaluate the correlation between the variables and chi-square to compare frequencies. The significance level adopted was 5%. The PCOS and control groups had similar ages and income, while the PCOS group had, as expected, higher BMI values. The majority of women in both groups self-declared as mixed race ([Table 1]). A higher score on the depression subscale was observed in women with PCOS compared to the control group (median 7.0 vs. 5.0, p=0.013). The PCOS group also presented a higher total score (median 16.0 [severe] vs. 13.0 [moderate]) and greater severity of anxiety (median 11.0 vs. 8.0) compared to the control group, although with only a tendency to significance (p=0.053) ([Table 2]). No correlation between HADS and BMI in the control group was observed (p=0.900). In the PCOS group, the depression score showed a significant correlation with BMI (r=0.352, p=0.026), HC (r=0.360, p=0.022), and WC (r=0.329, p=0.038). Depression can be present in more than 60% of women with PCOS [12]. These women can be up to eight times more likely to develop depression than healthy controls and have a four times greater chance of experiencing moderate to severe depressive symptoms. Although the mechanisms of depression in PCOS are not yet fully understood, changes in neurotransmitters and low-grade inflammation added to the body image concerns related to hyperandrogenism and overweight play a significant role [14] [15] [16]. This scenario may be worsened by the limited socioeconomic conditions faced by these women living in developing countries. Chronic exposure to stressors, such as comorbidities associated with the syndrome (obesity, insulin resistance, and dyslipidemia) and lifestyle factors (poor diet, sedentary lifestyle, and increased chronic stress), promotes a state of chronic low-grade inflammation in these patients. Chronic exposure to inflammatory cytokines impairs neuronal functions, affecting signaling, synthesis, reuptake, and release of neurotransmitters, promoting depressive mood, sleep disorders, and feelings of worthlessness, as well as more severe depressive symptoms [17] [18]. Neuroendocrine dysfunction in the hypothalamic-pituitary-gonadal axis in PCOS may also contribute to depression. The severity of hyperandrogenism is associated with greater mental stress in PCOS [19]. Chronic stress associated with PCOS complications, in turn, contributes to the release of cortisol and continuous hyperstimulation of the hypothalamic-pituitary-gonadal axis, forming a vicious cycle that can also contribute to depression [14]. Additionally, other common aspects of PCOS, such as infertility, excessive hair growth in areas generally associated with men, weight and body fat gain, acne, and alopecia, can contribute to anxiety, depression, and body image dissatisfaction in women with PCOS. The coexistence of anxiety and depression in individuals with PCOS can increase the suffering involved in the disease and interfere with the success of treatment [9], by reducing the quality of life and sexual satisfaction of these women [20]. Article published online: 22 January 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 22 January 2025
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 133 (02) , 105-107
Anxiety and Depression in Polycystic Ovary Syndrome: An Analysis Using the Hospital Anxiety and Depression Scale (HADS) in Women from a Low-Income Country
Polycystic ovary syndrome (PCOS) is a complex disease and the most common endocrine condition that affects women of reproductive age. Its prevalence ranges from 5% to 20%, characterized by hyperandrogenism, menstrual irregularities, and the presence of polycystic and dysfunctional ovaries [1] [2] [3] [4] [5] [6]. Women with PCOS often suffer from a variety of psychiatric disorders [7]. PCOS is associated with a greater likelihood of developing anxiety and depression, with moderate/severe symptoms, compromising the success of clinical treatment [8] [9]. The relationship between these psychiatric disorders and PCOS is not clear, but it is bidirectional and complex, resulting from interactions between sociocultural, family, individual factors, and the syndrome itself [7] [10]. The Hospital Anxiety and Depression Scale (HADS) is a screening instrument validated in Portuguese and widely used in clinical context, as it is a simple, objective and effective method for identifying and monitoring the presence and severity of possible or probable cases of anxiety and depression [9]. It contains 14 items divided into subscale A (anxiety) and subscale D (depression) that are scored separately or by the sum of A and D. The higher the score, the greater the level of anxiety and/or depression. For each item, a 4-point response scale is used, ranging from 0 – “absence of symptoms” to 3 – “maximum symptoms”. A score of 0 to 7 indicates no anxiety and/or depression, a score of 8 to 10 indicates mild anxiety and/or depression, a score of 11 to 14 indicates moderate anxiety and/or depression, and a score of 15 to 21 indicates anxiety and/or severe depression. For each subscale (A and D), 0 to 21 points can be obtained [8] [9] [10]. The average per capita income of Brazilians is US$318, and Brazil ranks 89th in the Human Development Index, according to the United Nations Organization [11] [12]. Low-income countries, such as Brazil, present a higher risk of psychiatric diseases due to less favorable socioeconomic conditions, making it not possible to extrapolate epidemiological data from PCOS patients who live in developed countries. Therefore, the objective of this study was to compare the HADS between Brazilian women with PCOS and a healthy control group, and its relationship with anthropometric variables. This case-control study was approved by the Research Ethics Committee of the Federal University of Minas Gerais (n. CAAE 05398918.2.0000.5149). Data were collected after consent and signing of the Informed Consent Form. This study was carried out from February to December 2023, with 47 women with PCOS, in which the diagnosis was established according to the criteria by the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine PCOS Consensus Workshop Group (Rotterdam) [13]. The control group included 47 healthy women, who presented regular ovulatory cycles, normal androgen levels, and no hirsutism. Women over 40 years of age, pregnant or undergoing nutritional monitoring were excluded. The groups were assessed by a trained nutritionist, who applied the HADS to both groups, measuring weight and height on a calibrated scale in both groups for body mass index (BMI) determination. Arm (AC), waist (WC), and hip circumferences (HC) were measured with an inelastic tape only in the PCOS group. Statistical analyses were performed using SPSS version 21.0 software. Normality was assessed using the Shapiro-Wilk test. Data were expressed as median and interquartile range (IQ: third quartile – first quartile). The Spearman test was performed to evaluate the correlation between the variables and chi-square to compare frequencies. The significance level adopted was 5%. The PCOS and control groups had similar ages and income, while the PCOS group had, as expected, higher BMI values. The majority of women in both groups self-declared as mixed race ([Table 1]). A higher score on the depression subscale was observed in women with PCOS compared to the control group (median 7.0 vs. 5.0, p=0.013). The PCOS group also presented a higher total score (median 16.0 [severe] vs. 13.0 [moderate]) and greater severity of anxiety (median 11.0 vs. 8.0) compared to the control group, although with only a tendency to significance (p=0.053) ([Table 2]). No correlation between HADS and BMI in the control group was observed (p=0.900). In the PCOS group, the depression score showed a significant correlation with BMI (r=0.352, p=0.026), HC (r=0.360, p=0.022), and WC (r=0.329, p=0.038). Depression can be present in more than 60% of women with PCOS [12]. These women can be up to eight times more likely to develop depression than healthy controls and have a four times greater chance of experiencing moderate to severe depressive symptoms. Although the mechanisms of depression in PCOS are not yet fully understood, changes in neurotransmitters and low-grade inflammation added to the body image concerns related to hyperandrogenism and overweight play a significant role [14] [15] [16]. This scenario may be worsened by the limited socioeconomic conditions faced by these women living in developing countries. Chronic exposure to stressors, such as comorbidities associated with the syndrome (obesity, insulin resistance, and dyslipidemia) and lifestyle factors (poor diet, sedentary lifestyle, and increased chronic stress), promotes a state of chronic low-grade inflammation in these patients. Chronic exposure to inflammatory cytokines impairs neuronal functions, affecting signaling, synthesis, reuptake, and release of neurotransmitters, promoting depressive mood, sleep disorders, and feelings of worthlessness, as well as more severe depressive symptoms [17] [18]. Neuroendocrine dysfunction in the hypothalamic-pituitary-gonadal axis in PCOS may also contribute to depression. The severity of hyperandrogenism is associated with greater mental stress in PCOS [19]. Chronic stress associated with PCOS complications, in turn, contributes to the release of cortisol and continuous hyperstimulation of the hypothalamic-pituitary-gonadal axis, forming a vicious cycle that can also contribute to depression [14]. Additionally, other common aspects of PCOS, such as infertility, excessive hair growth in areas generally associated with men, weight and body fat gain, acne, and alopecia, can contribute to anxiety, depression, and body image dissatisfaction in women with PCOS. The coexistence of anxiety and depression in individuals with PCOS can increase the suffering involved in the disease and interfere with the success of treatment [9], by reducing the quality of life and sexual satisfaction of these women [20]. Article published online: 22 January 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 69 (3) , 1-5
Dissociation of plasma oxyntomodulin levels from anthropometric measures and metabolic markers in women with polycystic ovary syndrome
Introduction: Oxyntomodulin (OXM) is a polypeptide hormone of the incretin family, which binds to the glucagon-like peptide 1 receptor, contributing to a reduction in caloric intake, an increase in energy expenditure, and weight loss in obese individuals. Polycystic ovary syndrome (PCOS) is a multifactorial condition characterized by reproductive and metabolic dysfunctions, with a high prevalence among overweight and obese women. This study aimed to investigate the correlation between clinical, anthropometric, endocrine, and metabolic variables and plasma OXM levels in [...] ABSTRACT Introduction: Oxyntomodulin (OXM) is a polypeptide hormone of the incretin family, which binds to the glucagon-like peptide 1 receptor, contributing to a reduction in caloric intake, an increase in energy expenditure, and weight loss in obese individuals. Polycystic ovary syndrome (PCOS) is a multifactorial condition characterized by reproductive and metabolic dysfunctions, with a high prevalence among overweight and obese women. This study aimed to investigate the correlation between clinical, anthropometric, endocrine, and metabolic variables and plasma OXM levels in
- 1 January 2025
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 69 (3) , 1-5
Open AccessDissociation of plasma oxyntomodulin levels from anthropometric measures and metabolic markers in women with polycystic ovary syndrome
Introduction: Oxyntomodulin (OXM) is a polypeptide hormone of the incretin family, which binds to the glucagon-like peptide 1 receptor, contributing to a reduction in caloric intake, an increase in energy expenditure, and weight loss in obese individuals. Polycystic ovary syndrome (PCOS) is a multifactorial condition characterized by reproductive and metabolic dysfunctions, with a high prevalence among overweight and obese women. This study aimed to investigate the correlation between clinical, anthropometric, endocrine, and metabolic variables and plasma OXM levels in [...] ABSTRACT Introduction: Oxyntomodulin (OXM) is a polypeptide hormone of the incretin family, which binds to the glucagon-like peptide 1 receptor, contributing to a reduction in caloric intake, an increase in energy expenditure, and weight loss in obese individuals. Polycystic ovary syndrome (PCOS) is a multifactorial condition characterized by reproductive and metabolic dysfunctions, with a high prevalence among overweight and obese women. This study aimed to investigate the correlation between clinical, anthropometric, endocrine, and metabolic variables and plasma OXM levels in
- Open Access
- 25 November 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-8
Plasma sTWEAK, diabetes mellitus, and bone fractures in postmenopausal women
- 25 November 2024
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-8
Open AccessPlasma sTWEAK, diabetes mellitus, and bone fractures in postmenopausal women
- Open Access
- 30 September 2024
- Published by Faculdade Ciências Médicas de Minas Gerais in REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS
- Vol. 8 (2) , 67-73
Caracterização clínica e de estilo de vida de pessoas com doença de crohn atendidas pela linha de cuidados gastrointestinais de um ambulatório em belo horizonte
INTRODUÇÃO: A Doença de Crohn (DC) é uma patologia crônica caracterizada pela inflamação intestinal que pode afetar todo o trato gastrointestinal. A incidência e prevalência da DC tem aumentado nos últimos anos em países ocidentais e o conhecimento acerca da fisiopatologia da doença ainda é escasso. OBJETIVO: Descrever o perfil clínico e de estilo de vida de pessoas vivendo com a DC para melhor manejo clínico e qualidade de vida destes indivíduos. METODOLOGIA: Trata-se de uma série de casos com 38 pacientes diagnosticados com Doença de Crohn atendidos no Ambulatório Ciências Médicas de Minas Gerais. RESULTADO: 55,3% era do sexo feminino, a idade média foi 47.6 anos. A maioria dos pacientes avaliados negaram tabagismo (n=21) e etilismo (n=23). 55,2% alegaram ser sedentários, o peso médio foi 67,4kg e a altura média 159.6cm. Metade da amostra não apresentou dados sobre o IMC. A frequência cardíaca média foi 68.9bpm, 39,4% pacientes foram classificados como normotensos, 44,7% usavam menos de 3 classes de medicamentos. O HDL médio foi de 53.5, o LDL médio de 112.5, o triglicérides médio foi 129.8, o TGO médio 25.7, o TGP médio 24.5, a glicemia em jejum média 95.4 e a hemoglobina glicada média 6.3. CONCLUSÃO: Os pacientes analisados apresentam um perfil clínico que corrobora com trabalhos publicados na literatura nacional. Além disso, é necessário realizar mais estudos nacionais na intervenção dos fatores de risco para melhora de qualidade vida para esta população.
- 30 September 2024
- Published by Faculdade Ciências Médicas de Minas Gerais in REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS
- Vol. 8 (2) , 67-73
Open AccessCaracterização clínica e de estilo de vida de pessoas com doença de crohn atendidas pela linha de cuidados gastrointestinais de um ambulatório em belo horizonte
INTRODUÇÃO: A Doença de Crohn (DC) é uma patologia crônica caracterizada pela inflamação intestinal que pode afetar todo o trato gastrointestinal. A incidência e prevalência da DC tem aumentado nos últimos anos em países ocidentais e o conhecimento acerca da fisiopatologia da doença ainda é escasso. OBJETIVO: Descrever o perfil clínico e de estilo de vida de pessoas vivendo com a DC para melhor manejo clínico e qualidade de vida destes indivíduos. METODOLOGIA: Trata-se de uma série de casos com 38 pacientes diagnosticados com Doença de Crohn atendidos no Ambulatório Ciências Médicas de Minas Gerais. RESULTADO: 55,3% era do sexo feminino, a idade média foi 47.6 anos. A maioria dos pacientes avaliados negaram tabagismo (n=21) e etilismo (n=23). 55,2% alegaram ser sedentários, o peso médio foi 67,4kg e a altura média 159.6cm. Metade da amostra não apresentou dados sobre o IMC. A frequência cardíaca média foi 68.9bpm, 39,4% pacientes foram classificados como normotensos, 44,7% usavam menos de 3 classes de medicamentos. O HDL médio foi de 53.5, o LDL médio de 112.5, o triglicérides médio foi 129.8, o TGO médio 25.7, o TGP médio 24.5, a glicemia em jejum média 95.4 e a hemoglobina glicada média 6.3. CONCLUSÃO: Os pacientes analisados apresentam um perfil clínico que corrobora com trabalhos publicados na literatura nacional. Além disso, é necessário realizar mais estudos nacionais na intervenção dos fatores de risco para melhora de qualidade vida para esta população.
- 18 July 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (7) , 1-3
Revisiting the utility of simplified Ferriman-Gallwey score (sFG) to predict hirsutism in Latin American women
- 18 July 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (7) , 1-3
Revisiting the utility of simplified Ferriman-Gallwey score (sFG) to predict hirsutism in Latin American women
- Open Access
- 24 June 2024
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e230271
Comparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil
Objective The aim of this study was to evaluate the efficacy of a self-assessment questionnaire for hirsutism using the latest cutoff values recommended by the Endocrine Society (ES) for Latin-American women and by the European Society for Human Reproduction and Embryology (ESHRE). Subject and methods Female premenopausal outpatients (n = 188) completed a self-assessment questionnaire, scoring hair presence across the nine areas evaluated by the modified Ferriman-Gallwey (mFG) scale. The results were compared with clinician-assessed scores rated independently by [...] ABSTRACT Objective The aim of this study was to evaluate the efficacy of a self-assessment questionnaire for hirsutism using the latest cutoff values recommended by the Endocrine Society (ES) for Latin-American women and by the European Society for Human Reproduction and Embryology (ESHRE). Subject and methods Female premenopausal outpatients (n = 188) completed a self-assessment questionnaire, scoring hair presence across the nine areas evaluated by the modified Ferriman-Gallwey (mFG) scale. The results were compared with clinician-assessed scores rated independently by
- 24 June 2024
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e230271
Open AccessComparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil
Objective The aim of this study was to evaluate the efficacy of a self-assessment questionnaire for hirsutism using the latest cutoff values recommended by the Endocrine Society (ES) for Latin-American women and by the European Society for Human Reproduction and Embryology (ESHRE). Subject and methods Female premenopausal outpatients (n = 188) completed a self-assessment questionnaire, scoring hair presence across the nine areas evaluated by the modified Ferriman-Gallwey (mFG) scale. The results were compared with clinician-assessed scores rated independently by [...] ABSTRACT Objective The aim of this study was to evaluate the efficacy of a self-assessment questionnaire for hirsutism using the latest cutoff values recommended by the Endocrine Society (ES) for Latin-American women and by the European Society for Human Reproduction and Embryology (ESHRE). Subject and methods Female premenopausal outpatients (n = 188) completed a self-assessment questionnaire, scoring hair presence across the nine areas evaluated by the modified Ferriman-Gallwey (mFG) scale. The results were compared with clinician-assessed scores rated independently by
- 13 May 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 109 (10) , e1911-e1921
Contrasting Bone Profiles in PCOS Are Related to BMI: A Systematic Review and Meta-analysis
Context Controversial results have emerged regarding whether polycystic ovary syndrome (PCOS) is protective or increases the risk of bone frailty. Objective This study investigated whether the PCOS condition affects bone parameters of premenopausal women. This is an update for a previous meta-analysis published in 2019. Data Sources We searched MEDLINE and Embase. Study Selection Studies were considered eligible for the update if published in English between October 1, 2018, and December 31, 2023. The diagnosis of PCOS should be based on National Institutes of Health criteria, the Rotterdam Consensus, Androgen Excess & PCOS Society criteria, or International Classification of Diseases codes in women over 18 years old. Only records with the Newcastle-Ottawa Scale ≥ 6 were selected for data extraction. Data Extraction Data were extracted by 2 independent reviewers. Data Synthesis We identified 31 studies that met the inclusion criteria for qualitative analysis from 3322 studies in the whole period (1990-2023). Overall, cross-sectional studies included 1822 individuals with PCOS and 1374 controls, while cohort studies incorporated 30 305 women with PCOS and 10,1907 controls. Contrasting profiles emerged after stratification using a body mass index (BMI) cutoff of 27 kg/m2. Individuals with PCOS and a BMI 2 exhibited lower vertebral and nonvertebral bone density, reduced bone turnover marker (osteocalcin), and increased bone resorption marker (C-terminal type I collagen) levels. Conversely, individuals with PCOS and a BMI ≥27 kg/m2 exhibited increased vertebral and nonvertebral bone mineral density, with no significant changes in bone formation and resorption markers (except osteocalcin). Conclusion The findings of this study alert for a low bone mass, low bone formation, and increased bone resorption PCOS with a BMI 2.
- 13 May 2024
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 109 (10) , e1911-e1921
Contrasting Bone Profiles in PCOS Are Related to BMI: A Systematic Review and Meta-analysis
Context Controversial results have emerged regarding whether polycystic ovary syndrome (PCOS) is protective or increases the risk of bone frailty. Objective This study investigated whether the PCOS condition affects bone parameters of premenopausal women. This is an update for a previous meta-analysis published in 2019. Data Sources We searched MEDLINE and Embase. Study Selection Studies were considered eligible for the update if published in English between October 1, 2018, and December 31, 2023. The diagnosis of PCOS should be based on National Institutes of Health criteria, the Rotterdam Consensus, Androgen Excess & PCOS Society criteria, or International Classification of Diseases codes in women over 18 years old. Only records with the Newcastle-Ottawa Scale ≥ 6 were selected for data extraction. Data Extraction Data were extracted by 2 independent reviewers. Data Synthesis We identified 31 studies that met the inclusion criteria for qualitative analysis from 3322 studies in the whole period (1990-2023). Overall, cross-sectional studies included 1822 individuals with PCOS and 1374 controls, while cohort studies incorporated 30 305 women with PCOS and 10,1907 controls. Contrasting profiles emerged after stratification using a body mass index (BMI) cutoff of 27 kg/m2. Individuals with PCOS and a BMI 2 exhibited lower vertebral and nonvertebral bone density, reduced bone turnover marker (osteocalcin), and increased bone resorption marker (C-terminal type I collagen) levels. Conversely, individuals with PCOS and a BMI ≥27 kg/m2 exhibited increased vertebral and nonvertebral bone mineral density, with no significant changes in bone formation and resorption markers (except osteocalcin). Conclusion The findings of this study alert for a low bone mass, low bone formation, and increased bone resorption PCOS with a BMI 2.
- Open Access
- 16 April 2024
- Published by Faculdade Ciências Médicas de Minas Gerais in REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS
- Vol. 8 (1) , 225-231
PERFIL CLÍNICO E DE ESTILO DE VIDA DE PACIENTES COM DISPEPSIA ASSISTIDOS PELA LINHA CONTÍNUA DE CUIDADOS DE UM AMBULATÓRIO PÚBLICO EM BELO HORIZONTE
Introdução: A dispepsia faz parte de um grupo heterogêneo de sintomas que acometem grande parte dos pacientes com queixas clínicas no abdome superior refletindo muitas vezes na sobrecarga aos serviços de saúde. Objetivo: Traçar o perfil clínico e de estilo de vida de pacientes diagnosticados com dispepsia assistidos pela Linha Contínua de Cuidados de um ambulatório de gastroenterologia em Belo Horizonte, Minas Gerais, Brasil. Método: Estudo transversal retrospectivo realizado com 221 prontuários de pacientes com diagnóstico de dispepsia. Foram coletadas informações clínicas, sociais e de estilo de vida. A análise estatística foi realizada utilizando o software R versão 4.2.1. As variáveis categóricas foram apresentadas de forma descritiva, por meio de distribuição de frequência absoluta e relativa. As variáveis contínuas foram descritas por média e desvio padrão (DP). Resultados: Dos pacientes incluídos, 75% (n=166) são do sexo feminino e média de idade igual a 58 ± 14,6 anos. O Índice de Massa Corporal (IMC) médio dos pacientes avaliados foi igual a 28,6 ± 6,1 kg/m2. Quando avaliado o estilo de vida dos pacientes, foi observado que o consumo de álcool foi mais frequente (59,73%) que o tabagismo (28,5%), e a maior parte dos pacientes estava em comportamento sedentário (57%). Conclusão: Conclui-se que a maioria dos pacientes com dispepsia avaliados por este estudo eram mulheres adultas em excesso de peso que faziam uso de bebida alcoólica e possuíam comportamento sedentário.
- 16 April 2024
- Published by Faculdade Ciências Médicas de Minas Gerais in REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS
- Vol. 8 (1) , 225-231
Open AccessPERFIL CLÍNICO E DE ESTILO DE VIDA DE PACIENTES COM DISPEPSIA ASSISTIDOS PELA LINHA CONTÍNUA DE CUIDADOS DE UM AMBULATÓRIO PÚBLICO EM BELO HORIZONTE
Introdução: A dispepsia faz parte de um grupo heterogêneo de sintomas que acometem grande parte dos pacientes com queixas clínicas no abdome superior refletindo muitas vezes na sobrecarga aos serviços de saúde. Objetivo: Traçar o perfil clínico e de estilo de vida de pacientes diagnosticados com dispepsia assistidos pela Linha Contínua de Cuidados de um ambulatório de gastroenterologia em Belo Horizonte, Minas Gerais, Brasil. Método: Estudo transversal retrospectivo realizado com 221 prontuários de pacientes com diagnóstico de dispepsia. Foram coletadas informações clínicas, sociais e de estilo de vida. A análise estatística foi realizada utilizando o software R versão 4.2.1. As variáveis categóricas foram apresentadas de forma descritiva, por meio de distribuição de frequência absoluta e relativa. As variáveis contínuas foram descritas por média e desvio padrão (DP). Resultados: Dos pacientes incluídos, 75% (n=166) são do sexo feminino e média de idade igual a 58 ± 14,6 anos. O Índice de Massa Corporal (IMC) médio dos pacientes avaliados foi igual a 28,6 ± 6,1 kg/m2. Quando avaliado o estilo de vida dos pacientes, foi observado que o consumo de álcool foi mais frequente (59,73%) que o tabagismo (28,5%), e a maior parte dos pacientes estava em comportamento sedentário (57%). Conclusão: Conclui-se que a maioria dos pacientes com dispepsia avaliados por este estudo eram mulheres adultas em excesso de peso que faziam uso de bebida alcoólica e possuíam comportamento sedentário.